Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery.
Yoshiaki ShojiKoshi KumagaiSatoshi KamiyaSatoshi IdaSouya NunobeManabu OhashiShoichi YoshimizuYusuke HoriuchiToshiyuki YoshioAkiyoshi IshiyamaToshiaki HirasawaTomo OsakoNoriko YamamotoJunko FujisakiTakeshi SanoNaoki HikiPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2019)
Single-tracer SN mapping by ICG fluorescence imaging with intraoperative diagnosis by OSNA assay is feasible and safe. SNs can be identified in most patients, without producing false-negative results. Further clinical trial to demonstrate the sensitivity is ongoing.
Keyphrases
- fluorescence imaging
- nucleic acid
- photodynamic therapy
- clinical trial
- end stage renal disease
- high resolution
- ejection fraction
- high throughput
- newly diagnosed
- minimally invasive
- chronic kidney disease
- positron emission tomography
- prognostic factors
- pet imaging
- computed tomography
- coronary artery bypass
- patient reported outcomes
- patients undergoing
- coronary artery disease
- percutaneous coronary intervention
- acute coronary syndrome
- phase ii